| A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy Participants (NCT02475148) | Janssen-Cilag International NV | 2015-06-01 |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma (NCT02026271) | Alaunos Therapeutics | 2015-06-01 |
| Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients (NCT02532764) | ProQR Therapeutics | 2015-06-01 |
| The Sustained Effects of Ketamine (NCT02708849) | Yale University | 2015-06-01 |
| A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants (NCT02471859) | Genentech, Inc. | 2015-06-01 |
| Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation (NCT02481154) | Institut de Recherches Internationales Servier | 2015-06-01 |
| A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis (NCT02469467) | KDL Inc. | 2015-06-01 |
| A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers (NCT02487433) | Pfizer | 2015-06-01 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120 (NCT02489513) | Agios Pharmaceuticals, Inc. | 2015-06-01 |
| A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants (NCT02475161) | Janssen Research & Development, LLC | 2015-06-01 |
| Male Circumcision (MC) Using the ShangRing™ Device in Malawi (NCT02309710) | FHI 360 | 2015-06-01 |
| Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers (NCT02395055) | Biocad | 2015-06-01 |
| Intravitreal Celecoxib for Chronic Uveitis (NCT02131012) | Vanderbilt University | 2015-06-01 |
| MK-3475/BCG in High Risk Superficial Bladder Cancer (NCT02324582) | Southern Illinois University | 2015-06-01 |
| 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer (NCT02488070) | Stanford University | 2015-06-01 |
| A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route (NCT02712554) | Charleston Laboratories, Inc | 2015-06-01 |
| Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer (NCT02422979) | Rakuten Medical, Inc. | 2015-06-01 |
| Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt (NCT02493985) | Baylor College of Medicine | 2015-06-01 |
| Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors (NCT02500199) | Hengrui Therapeutics, Inc. | 2015-06-01 |
| A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004) (NCT02477514) | Merck Sharp & Dohme LLC | 2015-06-01 |
| Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate (NCT02483208) | Bayer | 2015-06-01 |
| Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa (NCT02320812) | jCyte, Inc | 2015-06-01 |
| A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants (NCT02480439) | Takeda | 2015-06-01 |
| Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy (NCT02553785) | BioVentrix | 2015-06-01 |
| Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device (NCT02460770) | University Hospital, Toulouse | 2015-06-01 |
| SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma (NCT02500914) | Stemcentrx | 2015-06-01 |
| PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton (NCT02496910) | Yuhan Corporation | 2015-06-01 |
| Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer (NCT02157051) | University of Washington | 2015-06-01 |
| Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 (NCT02456701) | Celldex Therapeutics | 2015-06-01 |
| Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus (NCT02470637) | Mannkind Corporation | 2015-06-01 |
| Intraoperative Dual-modality Imaging in Renal Cell Carcinoma (NCT02497599) | Radboud University Medical Center | 2015-06-01 |
| A Single Ascending Dose Study of PCO371 in Healthy Volunteers (NCT02475616) | Chugai Pharmaceutical | 2015-06-01 |
| Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors (NCT02476123) | Kyowa Kirin Co., Ltd. | 2015-06-01 |
| Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects (NCT02470702) | Melinta Therapeutics, Inc. | 2015-06-01 |
| Safety, Tolerability and Pharmacokinetics of BIIB118 (PF-05251749) (NCT02443740) | Biogen | 2015-05-31 |
| A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects (NCT02604914) | NeuroDerm Ltd. | 2015-05-29 |
| Reduced-intensity Immunoablation and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Sclerosis (NCT03113162) | Makati Medical Center | 2015-05-29 |
| Pharmacokinetic Study of Topical GSK2894512 Cream (NCT02466152) | GlaxoSmithKline | 2015-05-28 |
| Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation (NCT02342613) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-28 |
| Single-Dose Phase 1 Study of TAK-792 (NCT02448719) | Takeda | 2015-05-27 |
| Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer (NCT02393625) | Novartis Pharmaceuticals | 2015-05-27 |
| Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects (NCT02365766) | Jason R. Brown | 2015-05-27 |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia (NCT02267707) | Celgene | 2015-05-27 |
| Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study (NCT02424916) | Nantes University Hospital | 2015-05-26 |
| Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults (NCT02431364) | Karyopharm Therapeutics Inc | 2015-05-26 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma (NCT02421185) | Janssen Research & Development, LLC | 2015-05-25 |
| A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis (NCT02034409) | VA Office of Research and Development | 2015-05-22 |
| A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL. (NCT02417285) | Celgene | 2015-05-22 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis (NCT02370706) | Novartis Pharmaceuticals | 2015-05-21 |
| The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese (NCT03092076) | Guangdong Provincial People's Hospital | 2015-05-20 |
| Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma (NCT02490800) | Basilea Pharmaceutica | 2015-05-20 |
| Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy (NCT02381080) | Janssen Research & Development, LLC | 2015-05-19 |
| Opioid Induced Gait Variability (NCT03121547) | Frederiksberg University Hospital | 2015-05-19 |
| Safety and Tolerability of Seroguard Use (NCT03640559) | Pharmasyntez | 2015-05-19 |
| Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02299518) | Alice Mims | 2015-05-18 |
| Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma (NCT02208362) | City of Hope Medical Center | 2015-05-18 |
| Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) (NCT02342353) | Washington University School of Medicine | 2015-05-18 |
| A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole (NCT02453022) | GlaxoSmithKline | 2015-05-18 |
| A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine (NCT02251288) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-05-18 |
| Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants (NCT02455856) | Janssen Cilag N.V./S.A. | 2015-05-18 |
| Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors (NCT02423057) | National Cancer Institute (NCI) | 2015-05-18 |
| Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass (NCT03500783) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2015-05-15 |
| SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients (NCT02283775) | Sanofi | 2015-05-15 |
| TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients (NCT02414945) | University Health Network, Toronto | 2015-05-15 |
| Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. (NCT02292550) | Novartis Pharmaceuticals | 2015-05-14 |
| Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms (NCT02403128) | Kamal Kishore, MD | 2015-05-14 |
| Radiolabeled Study of AG-221 in Healthy Male Subjects. (NCT02443168) | Celgene | 2015-05-14 |
| NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects (NCT03655522) | Algenis SpA | 2015-05-14 |
| Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy (NCT02434146) | University of Wisconsin, Madison | 2015-05-14 |
| Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) (NCT02349633) | Pfizer | 2015-05-14 |
| Pharmacodynamic Properties of CJ-12420 on Evening Dosing (NCT03043521) | HK inno.N Corporation | 2015-05-13 |
| Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study (NCT02461160) | Takeda | 2015-05-12 |
| Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma (NCT02425306) | Craig L Slingluff, Jr | 2015-05-12 |
| Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers (NCT03699774) | Daiichi Sankyo | 2015-05-12 |
| Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT02325401) | University of Cincinnati | 2015-05-11 |
| Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects (NCT02383888) | Boehringer Ingelheim | 2015-05-11 |
| Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants (NCT02448004) | Janssen Cilag N.V./S.A. | 2015-05-11 |
| Autologous Mesenchymal Stromal Cells for Multiple Sclerosis (NCT02495766) | Banc de Sang i Teixits | 2015-05-11 |
| Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755) | Roswell Park Cancer Institute | 2015-05-08 |
| Nasal Septum Autologous Chondrocytes Transplantation for Condylar Resorption After Orthognathic Surgery (NCT03137914) | Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto | 2015-05-08 |
| A Pharmacokinetic Study of Melphalan in Children (NCT02390544) | Children's Hospital Medical Center, Cincinnati | 2015-05-08 |
| Stereotactic Radiosurgery Dose Escalation for Brain Metastases (NCT02390518) | University of Utah | 2015-05-07 |
| Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma (NCT02400242) | Celgene | 2015-05-07 |
| Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC) (NCT02145637) | Yonsei University | 2015-05-07 |
| Comparative Pharmacokinetics of AFOLIA and US Gonal-f® RFF Redi-ject After Single Subcutaneous Application (NCT02459418) | Fertility Biotech AG | 2015-05-07 |
| Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02404220) | Gilead Sciences | 2015-05-06 |
| A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP) (NCT02452372) | Alnylam Pharmaceuticals | 2015-05-06 |
| Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) (NCT02387983) | Merck Sharp & Dohme LLC | 2015-05-06 |
| Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT02141477) | M.D. Anderson Cancer Center | 2015-05-06 |
| A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z (NCT02451891) | University of Oxford | 2015-05-06 |
| Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma (NCT02462525) | AbbVie | 2015-05-06 |
| D2C7 for Adult Patients With Recurrent Malignant Glioma (NCT02303678) | Darell Bigner | 2015-05-05 |
| Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment (NCT02402452) | Gilead Sciences | 2015-05-05 |
| Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin (NCT02348424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-05-05 |
| Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) (NCT02307149) | Viralytics | 2015-05-05 |
| Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head (NCT01605383) | Banc de Sang i Teixits | 2015-05-05 |
| Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT02187133) | University of California, San Francisco | 2015-05-05 |
| BI 409306 Cardiac Safety Trial in Healthy Volunteers (NCT02438683) | Boehringer Ingelheim | 2015-05-04 |
| Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction (NCT02446249) | MeiraGTx, LLC | 2015-05-04 |